heart failure

News

FDA gives breakthrough status to Biofourmis' heart failure D...

A digital therapeutic for patients with heart failure has been awarded breakthrough device status by the FDA – said by its developer Biofourmis to be the first time the US regulator h

News

First US patient gets total heart replacement with CARMAT de...

An experimental artificial heart developed by French medical device specialist CARMAT has been implanted into the first of 10 subjects due to be enrolled in a US trial.

News

Boehringer, Lilly hail Jardiance data in hard-to-treat heart...

Boehringer Ingelheim and Eli Lilly have the results they were hoping for in a large-scale study of Jardiance therapy in heart failure with preserved ejection fraction (HFpEF), a form of chr

News

AZ drug for hard-to-treat heart failure has mixed results in...

AstraZeneca has reported the first phase 2 results with a drug for heart failure with preserved ejection fraction (HFpEF), showing it worked as expected but wasn't able to provide any clini

News

Farxiga faces first heart failure rival as EU OKs Boehringer...

AstraZeneca's SGLT2 inhibitor Farxiga has been growing fast thanks to a first-in-class approval in heart failure, but will now have to share the market with Boehringer Ingelheim and Eli Lil

News